Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -49.05x is 109% below its 5-year average of -23.48x, near the high end of its 5-year range (-226.25x–-1.57x).
136.60% below its 12-month average of -20.73x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2026 (2026-06-30): -1.57x.
INTEREST COVERAGE RATIO
-49.05x
INTEREST COVERAGE RATIO AVG TTM
-20.73x
INTEREST COVERAGE RATIO AVG 3Y
-31.47x
INTEREST COVERAGE RATIO AVG 5Y
-23.48x
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-136.60%
CURRENT VS 3Y AVG
-55.84%
CURRENT VS 5Y AVG
-108.87%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-6.03x
median of 502 covered companies
CURRENT VS SECTOR MEDIAN
-714.11%
vs the sector median at left
Nyxoah S.A.
Market Cap
$144.10M
Interest Coverage Ratio
-49.05x
TTM Avg
-20.73x
3Y Avg
-31.47x
5Y Avg
-23.48x
Market Cap
$142.56M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$143.95M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$142.01M
Interest Coverage Ratio
-2.75x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$140.67M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$146.26M
Interest Coverage Ratio
-29.32x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$146.42M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$139.73M
Interest Coverage Ratio
-8.06x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$137.45M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Nyxoah S.A. (NYXH) | $144.10M | -49.05x | -20.73x | -31.47x | -23.48x |
| Protara Therapeutics, Inc. (TARA)vs › | $142.56M | N/A | N/A | N/A | N/A |
| Korsana Biosciences, Inc. (KRSA)vs › | $143.95M | N/A | N/A | N/A | N/A |
| Sutro Biopharma, Inc. (STRO)vs › | $142.01M | -2.75x | N/A | N/A | N/A |
| Immuneering Corporation (IMRX)vs › | $140.67M | N/A | N/A | N/A | N/A |
| Acumen Pharmaceuticals, Inc. (ABOS)vs › | $146.26M | -29.32x | N/A | N/A | N/A |
| Anavex Life Sciences Corp. (AVXL)vs › | $146.42M | N/A | N/A | N/A | N/A |
| Fortress Biotech, Inc. (FBIOP)vs › | $139.73M | -8.06x | N/A | N/A | N/A |
| Alpha Cognition Inc (ACOG)vs › | $137.45M | N/A | N/A | N/A | N/A |
| NervGen Pharma Corp. Common stock (NGEN)vs › | $149.18M | N/A | N/A | N/A | N/A |
Interest Coverage
-49.0x
Debt/Equity
0.63
Current Ratio
2.38
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | -1.57x |
| 2026-03-31 | -17.47x |
| 2025-09-30 | -34.56x |
| 2025-06-30 | -29.32x |
| 2025-03-31 | -29.74x |
| 2024-12-31 | -13.46x |
| 2024-09-30 | -22.29x |
| 2024-06-30 | -37.80x |
| 2024-03-31 | -113.19x |
| 2023-12-31 | -208.91x |
| 2023-09-30 | -159.89x |
| 2023-06-30 | -15.33x |
| 2023-03-31 | -175.25x |
| 2022-12-31 | -226.25x |
| 2022-09-30 | -3.55x |
| 2022-06-30 | -3.26x |
| 2022-03-31 | -21.41x |
| 2021-12-31 | -9.87x |
| 2021-09-30 | -11.91x |
| 2021-06-30 | -10.98x |
| 2021-03-31 | -16.38x |
| 2020-06-30 | -19.44x |
| 2020-03-31 | -6.10x |
